Using both PSMA and GRP-R imaging in the same patient [41], it would be possible to detect both the androgen regulated PSMA expression adenocarcinomas as well as progression to the PSMA/AR negative NEPC. This evidence concerns the gene FOLH1 and adenocarcinoma.